Changeflow GovPing Healthcare & Life Sciences Insulin Dosage Patent Application by Stone, Mik...
Routine Notice Added Final

Insulin Dosage Patent Application by Stone, Mikhno, Turksoy, and Grossman

Favicon for changeflow.com USPTO Patent Applications - Health Informatics (G16H)
Published
Detected
Email

Summary

USPTO published patent application US20260096775A1 titled 'Open Loop Intelligent Dosing' on April 9, 2026. The application covers systems and techniques for generating personalized insulin dosage recommendations by building a physiological model from a patient's historical glucose and insulin data, estimating the impact of meal consumption on glucose levels, and outputting a personalized meal bolus insulin dose recommendation. The application was filed on September 16, 2025 under Application No. 19330568, with four named inventors: Michael P. Stone, Arthur Mikhno, Kamuran Turksoy, and Benyamin Grossman. This is a published patent application record; it has not yet been granted and creates no immediate compliance obligations.

“Systems, devices, and techniques are disclosed for providing personalized insulin dosage recommendations for a patient.”

USPTO , verbatim from source
Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors USPTO Patent Applications - Health Informatics (G16H) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 146 changes logged to date.

What changed

USPTO published patent application US20260096775A1 for an open-loop insulin dosing system. The application discloses a method for generating personalized insulin dosage recommendations using a physiological model trained on a patient's historical glucose and insulin data over a meal-consumption window. The model estimates meal impact on glucose values and generates a meal bolus recommendation based on a meal size input. CPC classifications include A61B 5/486 (glucose monitoring), A61B 5/14532 (continuous glucose measurement), and G16H 20/17 (insulin therapy).

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

OPEN LOOP INTELLIGENT DOSING

Application US20260096775A1 Kind: A1 Apr 09, 2026

Inventors

Michael P. STONE, Arthur MIKHNO, Kamuran TURKSOY, Benyamin GROSMAN

Abstract

Systems, devices, and techniques are disclosed for providing personalized insulin dosage recommendations for a patient. In some aspects, a method includes generating a physiological model for estimating glucose values of the patient based on historical data, the historical data comprising glucose value history and insulin dosage history for a time window during which the patient consumed a plurality of meals. The method also may include estimating, using the physiological model and the historical data, an impact of the plurality of meals on the glucose values of the patient, and receiving a first meal size indication of a first meal for consumption by the patient. The method may also include outputting a first meal bolus insulin dose recommendation based on the impact of the plurality of meals on the glucose values of the patient and the first meal size indication.

CPC Classifications

A61B 5/486 A61B 5/14532 A61B 5/742 G16H 10/60 G16H 20/17

Filing Date

2025-09-16

Application No.

19330568

View original document →

Get daily alerts for USPTO Patent Applications - Health Informatics (G16H)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 9th, 2026
Instrument
Notice
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US20260096775A1

Who this affects

Applies to
Patent applicants Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent filing Glucose monitoring systems Insulin delivery systems
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Medical Devices

Get alerts for this source

We'll email you when USPTO Patent Applications - Health Informatics (G16H) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!